Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Takeda signs strategic-level outsourcing deal with PRA

R&D deal adds to cutbacks strategy with predicted annual savings of $175m

- PMLiVE

Safe from harm?

Which healthcare systems inspire patient confidence?

- PMLiVE

Horizon swoops on Raptor to add rare disease products

Gains two new orphan medicines through the $800m deal

- PMLiVE

GSK and J&J file sirukumab for rheumatoid arthritis in EU

If approved it will compete with Roche blockbuster Actemra

- PMLiVE

A new era of collaboration

Looking at the factors driving this change and assessing the benefits

Summit takes clinical trial participant search online

Hopes to broaden reach of its Duchenne muscular dystrophy study

- PMLiVE

Vikas Sinha joins Verona as non-executive director

Brings strong US and financial experience to the UK drug development firm

- PMLiVE

Who’s listening? Why a tailored approach to education improves outcomes

In an increasingly resource-constrained environment with a growing need to show measurable impact in patient outcomes, medical education needs to smarten up. A blanket approach is no longer enough: we...

AstraZeneca AZ

AZ looks beyond diabetes with Forxiga trials

Will investigate dapagliflozin in kidney disease and heart failure

UK to establish a digital academy for healthcare professionals

NHS technology plans will also see 12 trusts act as digitisation pioneers

- PMLiVE

Sanofi sets up diabetes joint venture with Google’s Verily

Onduo aims to bring together medicines with new devices and software

Targeting’s Book of the Dead

Companies often carry harmful old genes in their DNA

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links